Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto and Sitagliptin Effects on GLP-1
NCT03717688Phase 4Completed
- Start
- May 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sacubitril + valsartan in diabetes mellitus (DM) and heart failure (HF). Started May 2018; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
diabetes mellitus (DM)heart failure (HF)
Beyond the preview
Go deeper on NCT03717688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03717688.